News

CDC investigating accidental anthrax shipment to labs


 

References

The Centers for Disease Control and Prevention is investigating a shipment of anthrax mistakenly sent to labs in the United States and abroad from the Department of Defense, the agency said in a May 30 announcement.

The presence of anthrax was confirmed after a laboratory working with the DOD reported being able to grow live Bacillus anthracis bacteria, although an inactive agent was expected. The lab was working with the DOD to develop a diagnostic test to identify biological threats, the CDC reported.

The accidental shipment is not believed to pose a risk to the public, the CDC said. Samples are being sent to the CDC or Laboratory Response Network labs for testing, and CDC officials are performing onsite investigations at the laboratories involved.

mrajaraman@frontlinemedcom.com

Recommended Reading

M.O.R.E. means less delirium in ICU
MDedge Family Medicine
Experimental vaccine may have worked on Ebola-exposed physician
MDedge Family Medicine
Ebola-positive healthcare worker to be admitted to NIH
MDedge Family Medicine
CPAP by helmet better than face mask in children
MDedge Family Medicine
U.S. volunteer infected with Ebola in Sierra Leone
MDedge Family Medicine
Condition of Ebola patient brought to U.S. worsens
MDedge Family Medicine
U.S. grants drug company $12 million to develop Ebola drug
MDedge Family Medicine
CDC Ebola vaccine trial underway in Sierra Leone
MDedge Family Medicine
AAN: Largest neuroleptic malignant syndrome study finds predictors of poor outcome
MDedge Family Medicine
Larger-gauge PICCs, VTE history increase PICC-DVT risk
MDedge Family Medicine